Hexagon Vitamin has obtained capital markets regulator Sebi’s approval to lift as much as Rs 600 crore by means of an preliminary public providing (IPO).
The corporate’s public difficulty consists of a recent difficulty of fairness shares aggregating to Rs 100 crore, and a proposal on the market (OFS) of as much as 30,113,918 fairness shares, in keeping with the draft purple herring prospectus (DRHP).
The OFS includes sale of as much as 77 lakh shares by Arun Purushottam Kelkar, as much as 61.36 lakh shares by Subhash Purushottam Kelkar, as much as 15 lakh shares by Anuradha Arun Kelkar, as much as 25 lakh shares by Nutan Subhash Kelkar, as much as 1.22 crore shares by Somerset Indus Healthcare Fund I Ltd and as much as 73,668 shares by Mayur Sirdesai.
Comments
0 comments